Form 4: Guardant Health Director's RSU Vesting

Guardant Health Director Manuel Hidalgo Medina reported the vesting and conversion of 232 restricted stock units into common stock.

Summary

• Manuel Hidalgo Medina, a Director at Guardant Health, Inc. (GH), reported an insider transaction on November 17, 2025.
• The transaction involved the acquisition of 232 shares of Guardant Health Common Stock.
• These shares resulted from the conversion of 232 Restricted Stock Units (RSUs) that had vested.
• The original RSU award was granted on July 17, 2024, with 25% of the award vesting on its one-year anniversary, July 17, 2025.
• Following this transaction, Medina directly owns 1,047 shares of Common Stock and 7,425 Restricted Stock Units.

Sentiment

Score: 7

Explanation: The filing reports a routine vesting of restricted stock units for a director, indicating a scheduled compensation event and an increase in direct equity ownership, which is generally positive for aligning interests.

Positives

• Director Manuel Hidalgo Medina increased his direct beneficial ownership of Guardant Health common stock by 232 shares through the vesting of Restricted Stock Units.
• The vesting event demonstrates the company's compensation structure aligning director interests with shareholder value over time.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value through equity ownership.

Next Steps

• The remaining 75% of the RSU award will vest monthly over the three-year period following July 17, 2025.

Key Dates

Recommendation

This Form 4 reports a routine vesting of restricted stock units for a director, which is a scheduled compensation event and does not provide new material information to alter an investment recommendation. It reflects ongoing equity alignment rather than a strategic shift or significant financial event.

Keywords

Guardant Health, GH, Form 4, Insider Transaction, RSU Vesting, Director, Stock Ownership